T. Vulliamy

1.1k total citations
17 papers, 765 citations indexed

About

T. Vulliamy is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Vulliamy has authored 17 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Vulliamy's work include RNA regulation and disease (5 papers), Neonatal Health and Biochemistry (5 papers) and Methemoglobinemia and Tumor Lysis Syndrome (4 papers). T. Vulliamy is often cited by papers focused on RNA regulation and disease (5 papers), Neonatal Health and Biochemistry (5 papers) and Methemoglobinemia and Tumor Lysis Syndrome (4 papers). T. Vulliamy collaborates with scholars based in United Kingdom, United States and Italy. T. Vulliamy's co-authors include Inderjeet Dokal, Philip J. Mason, S. W. Knight, Michele D’Urso, Lucio Luzzatto, G. Martini, Daniela Toniolo, Rosanna Dono, M. Graziella Persico and Giuseppe Viglietto and has published in prestigious journals such as Nucleic Acids Research, Blood and The American Journal of Human Genetics.

In The Last Decade

T. Vulliamy

17 papers receiving 749 citations

Peers

T. Vulliamy

PHYSI

PPCH

GENET

HEMAT

Nicole Lucien France

G Mastroberardino Italy

Mark Hills Canada

Isabelle Guilleret Switzerland

Claude Lopez France

S. Takegawa Japan

Colleen Byrnes United States

Joseph A. Grasso United States

Y. Terry Lee United States

Virginia Vega-Warner United States

Nicole Lucien France

T. Vulliamy

245 ×0.6

236 ×0.7

PHYSI

47 ×0.3

PPCH

63 ×0.5

GENET

217 ×1.9

HEMAT

Citations per year, relative to T. Vulliamy T. Vulliamy (= 1×) peers Nicole Lucien

Countries citing papers authored by T. Vulliamy

Since Specialization

Citations

This map shows the geographic impact of T. Vulliamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Vulliamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Vulliamy more than expected).

Fields of papers citing papers by T. Vulliamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Vulliamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Vulliamy. The network helps show where T. Vulliamy may publish in the future.

Co-authorship network of co-authors of T. Vulliamy

This figure shows the co-authorship network connecting the top 25 collaborators of T. Vulliamy. A scholar is included among the top collaborators of T. Vulliamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Vulliamy. T. Vulliamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Luzzatto, Lucio, Germana Bancone, Pierre‐Antoine Dugué, et al.. (2024). New WHO classification of genetic variants causing G6PD deficiency. Bulletin of the World Health Organization. 102(8). 615–617. 12 indexed citations

Bhagat, Tushar D., M. Kirwan, Cyril Gitiaux, et al.. (2012). Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica. 98(3). 334–338. 73 indexed citations

Plagnol, Vincent, Richard Beswick, M. Kirwan, et al.. (2011). Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica. 97(4). 524–528. 32 indexed citations

Vuong, Lam, Philipp Hemmati, Stefan Neuburger, et al.. (2010). Reduced-Intensity Conditioning Using Fludarabine and Antithymocyte Globulin Alone Allows Stable Engraftment in a Patient with Dyskeratosis Congenita. Acta Haematologica. 124(4). 200–203. 22 indexed citations

Percy, Melanie J., et al.. (2005). Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b5 reductase: An aid to determine recessive congenital methemoglobinemia status in an infant. Blood Cells Molecules and Diseases. 36(1). 81–90. 18 indexed citations

Lim, Fang Shiang, et al.. (2005). An Ashkenazi Jewish woman presenting with favism. Journal of Clinical Pathology. 58(3). 317–319. 16 indexed citations

Avery, S, E. Nadal, David Marín, et al.. (2004). Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib. Leukemia Research. 28. 75–77. 9 indexed citations

Almeida, António, et al.. (2001). Fludarabine‐based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. British Journal of Haematology. 112(2). 427–429. 23 indexed citations

Kaeda, Jaspal, Sanjay Beesoon, T. Vulliamy, et al.. (1999). Three major G6PD‐deficient polymorphic variants identified among the Mauritian population. British Journal of Haematology. 104(4). 849–854. 20 indexed citations

10.

Knight, S. W., Nina S. Heiss, T. Vulliamy, et al.. (1999). X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene. The American Journal of Human Genetics. 65(1). 50–58. 187 indexed citations

11.

Knight, S. W., T. Vulliamy, Nina S. Heiss, et al.. (1998). 1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.. Journal of Medical Genetics. 35(12). 993–996. 30 indexed citations

12.

Vulliamy, T., S. W. Knight, Inderjeet Dokal, & Philip J. Mason. (1997). Skewed X-Inactivation in Carriers of X-Linked Dyskeratosis Congenita. Blood. 90(6). 2213–2216. 52 indexed citations

13.

Vulliamy, T., S. W. Knight, Inderjeet Dokal, & Philip J. Mason. (1997). Skewed X-Inactivation in Carriers of X-Linked Dyskeratosis Congenita. Blood. 90(6). 2213–2216. 5 indexed citations

14.

Knight, S. W., T. Vulliamy, Gian Luca Forni, et al.. (1996). Fine mapping of the dyskeratosis congenita locus in Xq28.. Journal of Medical Genetics. 33(12). 993–995. 24 indexed citations

15.

McMullin, Mary Frances, T. Vulliamy, Julie A. Adams, et al.. (1992). Systemic Mastocytosis with an Abnormally Expanded T-Cell Clone. Leukemia & lymphoma. 6(4-5). 419–422. 1 indexed citations

16.

Macdonald, D., Yawei Jiang, David Swirsky, et al.. (1991). Acute myeloid leukaemia relapsing following interleukin‐2 treatment expresses the alpha chain of the interleukin‐2 receptor. British Journal of Haematology. 77(1). 43–49. 25 indexed citations

17.

Persico, M. Graziella, Giuseppe Viglietto, G. Martini, et al.. (1986). Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Research. 14(6). 2511–2522. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact